within Pharmacolibrary.Drugs.ATC.N;

model N01AH02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 3.2 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Alfentanil is a potent, short-acting synthetic opioid analgesic belonging to the phenylpiperidine class. It is primarily used as an adjunct to anesthesia, for induction and maintenance of analgesia during surgical procedures requiring analgesia and sedation. Approved for clinical use, it is commonly administered intravenously due to its rapid onset and short duration of action.</p><h4>Pharmacokinetics</h4><p>Healthy adults, single intravenous bolus dose, pharmacokinetics based on two-compartment model.</p><h4>References</h4><ol><li><p>Scholz, J, et al., &amp; Schulz, M (1996). Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. <i>Clinical pharmacokinetics</i> 31(4) 275–292. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199631040-00004&quot;>10.2165/00003088-199631040-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8896944/&quot;>https://pubmed.ncbi.nlm.nih.gov/8896944</a></p></li><li><p>Hughes, LM, et al., &amp; Nestor, CC (2023). Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review. <i>Anaesthesia</i> 78(5) 620–625. DOI:<a href=&quot;https://doi.org/10.1111/anae.15952&quot;>10.1111/anae.15952</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36562193/&quot;>https://pubmed.ncbi.nlm.nih.gov/36562193</a></p></li><li><p>Ziesenitz, VC, et al., &amp; van den Anker, JN (2018). Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review. <i>Clinical pharmacokinetics</i> 57(2) 125–149. DOI:<a href=&quot;https://doi.org/10.1007/s40262-017-0569-6&quot;>10.1007/s40262-017-0569-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28688027/&quot;>https://pubmed.ncbi.nlm.nih.gov/28688027</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N01AH02;
